Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer - Concepedia

Concepedia

Publication | Open Access

Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer

DOI Full Paper Access

157

Citations

15

References

2018

Year

Stephan Krüger, Volker Heinemann, C. M. D. Ross, Frank Diehl, D. Nagel, Steffen Ormanns, Sibylle Liebmann, I. Prinz-Bravin, C. Benedikt Westphalen, Michael Haas,

Annals of Oncology

Abstract

mutKRAS ctDNA kinetics appear to be a powerful and highly specific tool in early response prediction and therapy monitoring of advanced PC patients receiving chemotherapy.

References

	Year	Citations

Page 1